Brief: Bioretec Says Submitted Additional Information Requested By U.S. FDA For Registration Of Remeos Trauma Screws

Bioretec Oy

04/01/2023 02:48

Jan 3 (Reuters) - Bioretec Oy  BRETEC.HE :
    * BIORETEC HAS SUBMITTED ADDITIONAL INFORMATION REQUESTED BY
THE
FDA FOR US REGISTRATION OF REMEOS™ TRAUMA SCREWS, AND THE
ESTIMATED APPROVAL TIMELINE OF APRIL 2023 REMAINS UNCHANGED
    * BIORETEC'S ESTIMATE FOR RECEIVAL OF U.S. MARKET
AUTHORIZATION
REMAINS UNCHANGED IN APRIL 2023

Source text for Eikon:  ID:nPn4GCGWva 
Further company coverage:  BRETEC.HE 
 ((reuters.briefs@thomsonreuters.com;))